Showing promise in the arena of weight management therapy, retatrutide presents a different method. Unlike many available medications, retatrutide operates as a twin agonist, at once engaging both glucagon-like peptide-1 (GLP-1) and glucose-responsive insulinotropic hormone (GIP) binding sites. This simultaneous activation fosters various beneficia… Read More